Company or ticker...

Catalyst Pharmaceuticals

Catalyst commercializes therapies for rare neuromuscular and neurological diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

CPRX

3.9B

6.5

18.1

34.96%

Key Facts

M. Cap

PS

PE

YTD

3.9B

6.5

18.1

34.96%

10MA

20MA

50MA

200MA

$CPRX